Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes

被引:43
作者
Harvey, BG [1 ]
McKinney, RL
Rosengart, T
Lesser, ML
Crystal, RG
机构
[1] Cornell Univ, Weill Med Coll, Div Pulm & Crit Care Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Inst Med Genet, New York, NY 10021 USA
[3] Evanston NW Healthcare, Dept Cardiothorac Surg, Evanston, IL 60201 USA
[4] Long Isl Jewish Res Inst, Biostat Unit, Manhasset, NY 11050 USA
关键词
Ad vectors; innate responses; human; gene therapy; IL-6; anti-Ad-neutralizing metabolism;
D O I
10.1006/mthe.2002.0658
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Administration of adenovirus (Ad) vectors to animals induces innate immune responses, typified by elevated interleukin-6 (IL-6). To assess innate responses to Ad vectors in humans, we evaluated serum IL-6 following administration of E1(-)E3(-) Ad vectors to different human hosts and the relationship among peak IL-6 and peak anti-Ad neutralizing antibodies. We administered: 1) Ad(GV)CFTR.10, a vector carrying the normal human CFTR cDNA (3 x 10(7) to 2 x 10(10) particle units (pu)) to airways of individuals with cystic fibrosis (CF); 2) Ad(GV)VEGF121.10, a vector carrying the normal human vascular endothelial growth factor (VEGF)121 cDNA, to the myocardium (4 X 108 to 4 X 1010 pu) of individuals with coronary artery disease (CAD) and to lower extremity muscles (4 X 10(8) to 4 X 10(9.5) pu) of individuals with peripheral vascular disease (PVD); and 3) Ad(GV)CD.10, a vector carrying the Escherichia coli cytosine deaminase gene to skin (7 X 10(7) to 7 x 10(9) pu) and airways (7 X 10(8) to 7 X 10(10) pu) of normal individuals and to liver metastasis (4 x 10(8) to 4 x 10(9) pu) of individuals with colon carcinoma. IL-6 increased mildly (up to 220 pg/ml) following vector administration to skin and lung airways of normal individuals and of individuals with CF, and to muscle and liver metastasis of individuals with PVD and colon cancer, respectively. IL-6 responses were higher (up to 1100 pg/ml) following myocardial administration. Control individuals who had chest surgery and bronchoscopy, but no vector administration, had comparable IL-6 increases. Thus, both administration of Ad vectors of humans up to 10(10) pu and the procedures used to administer the vectors elicit systemic IL-6 responses. There was no correlation among peak IL-6 and peak anti-Ad antibodies. These observations indicate that the innate host responses following administration of Ad vectors to humans may result from the procedures used to administer the vector, and from the vector per se.
引用
收藏
页码:287 / 297
页数:11
相关论文
共 49 条
[31]   Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung [J].
Peng, YF ;
Trevejo, J ;
Zhou, JL ;
Marino, MW ;
Crystal, RG ;
Falck-Pedersen, E ;
Elkon, KB .
JOURNAL OF VIROLOGY, 1999, 73 (06) :5098-5109
[32]   INVIVO TRANSFER OF THE HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE TO THE AIRWAY EPITHELIUM [J].
ROSENFELD, MA ;
YOSHIMURA, K ;
TRAPNELL, BC ;
YONEYAMA, K ;
ROSENTHAL, ER ;
DALEMANS, W ;
FUKAYAMA, M ;
BARGON, J ;
STIER, LE ;
STRATFORDPERRICAUDET, L ;
PERRICAUDET, M ;
GUGGINO, WB ;
PAVIRANI, A ;
LECOCQ, JP ;
CRYSTAL, RG .
CELL, 1992, 68 (01) :143-155
[33]   Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA [J].
Rosengart, TK ;
Lee, LY ;
Patel, SR ;
Kligfield, PD ;
Okin, PM ;
Hackett, NR ;
Isom, OW ;
Crystal, RG .
ANNALS OF SURGERY, 1999, 230 (04) :466-470
[34]   Angiogenesis gene therapy - Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease [J].
Rosengart, TK ;
Lee, LY ;
Patel, SR ;
Sanborn, TA ;
Parikh, M ;
Bergman, GW ;
Hachamovitch, R ;
Szulc, M ;
Kligfield, PD ;
Okin, PM ;
Hahn, RT ;
Devereux, RB ;
Post, MR ;
Hackett, NR ;
Foster, T ;
Grasso, TM ;
Lesser, ML ;
Isom, OW ;
Crystal, RG .
CIRCULATION, 1999, 100 (05) :468-474
[35]   Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors [J].
Schnell, MA ;
Zhang, Y ;
Tazelaar, J ;
Gao, GP ;
Yu, QC ;
Qian, R ;
Chen, SJ ;
Varnavski, AN ;
LeClair, C ;
Raper, SE ;
Wilson, JM .
MOLECULAR THERAPY, 2001, 3 (05) :708-722
[36]  
Sugi K, 2000, Jpn J Thorac Cardiovasc Surg, V48, P161
[37]   BAL induces an increase in peripheral blood neutrophils and cytokine levels in healthy volunteers and patients with pneumonia [J].
Terashima, T ;
Amakawa, K ;
Matsumaru, A ;
van Eeden, S ;
Hogg, JC ;
Yamaguchi, K .
CHEST, 2001, 119 (06) :1724-1729
[38]   Manipulation of the cytoplasmic and transmembrane domains alters cell surface levels of the coxsackie-adenovirus receptor and changes the efficiency of adenovirus infection [J].
Van't Hof, W ;
Crystal, RG .
HUMAN GENE THERAPY, 2001, 12 (01) :25-34
[39]   Adenoviruses as gene-delivery vehicles [J].
Wilson, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (18) :1185-1187
[40]   Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ [J].
Wolff, G ;
Worgall, S ;
vanRooijen, N ;
Song, WR ;
Harvey, BG ;
Crystal, RG .
JOURNAL OF VIROLOGY, 1997, 71 (01) :624-629